Hiroyuki Hata

2.9k total citations
96 papers, 1.5k citations indexed

About

Hiroyuki Hata is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Hiroyuki Hata has authored 96 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 33 papers in Hematology and 26 papers in Oncology. Recurrent topics in Hiroyuki Hata's work include Multiple Myeloma Research and Treatments (30 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Peptidase Inhibition and Analysis (13 papers). Hiroyuki Hata is often cited by papers focused on Multiple Myeloma Research and Treatments (30 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Peptidase Inhibition and Analysis (13 papers). Hiroyuki Hata collaborates with scholars based in Japan, United States and China. Hiroyuki Hata's co-authors include Hiroaki Mitsuya, Yutaka Okuno, Yawara Kawano, Hiromitsu Matsuzaki, Shiho Fujiwara, Fumihiko Matsuno, Naoko Wada, Takayuki Ezaki, Pham Hong Nhung and Hiro Tatetsu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Hiroyuki Hata

93 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Hata Japan 25 788 447 439 286 167 96 1.5k
David Gallardo Spain 26 558 0.7× 557 1.2× 492 1.1× 391 1.4× 138 0.8× 112 2.1k
Benigno C. Valdez United States 26 1.7k 2.2× 388 0.9× 295 0.7× 167 0.6× 93 0.6× 94 2.3k
Lotte K. Vogel Denmark 27 772 1.0× 485 1.1× 191 0.4× 158 0.6× 142 0.9× 59 2.0k
Junji Nishida Japan 24 1.0k 1.3× 539 1.2× 724 1.6× 642 2.2× 212 1.3× 78 2.4k
Clarissa Uhlar United States 15 934 1.2× 551 1.2× 538 1.2× 457 1.6× 177 1.1× 35 1.9k
J A Kant United States 20 585 0.7× 318 0.7× 225 0.5× 350 1.2× 225 1.3× 31 1.7k
Nadine Weich United States 15 806 1.0× 344 0.8× 258 0.6× 334 1.2× 396 2.4× 23 1.7k
Susan B. Dillon United States 24 584 0.7× 234 0.5× 345 0.8× 595 2.1× 266 1.6× 41 1.7k
N. N. Teng United States 21 560 0.7× 300 0.7× 189 0.4× 497 1.7× 265 1.6× 37 2.1k
Junichiro Fujimoto Japan 28 858 1.1× 397 0.9× 257 0.6× 720 2.5× 94 0.6× 124 2.6k

Countries citing papers authored by Hiroyuki Hata

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Hata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Hata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Hata more than expected).

Fields of papers citing papers by Hiroyuki Hata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Hata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Hata. The network helps show where Hiroyuki Hata may publish in the future.

Co-authorship network of co-authors of Hiroyuki Hata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Hata. A scholar is included among the top collaborators of Hiroyuki Hata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Hata. Hiroyuki Hata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuo, Misaki, Takaharu Ueno, Kazuaki Monde, et al.. (2022). Identification and characterization of a novel enhancer in the HTLV-1 proviral genome. Nature Communications. 13(1). 2405–2405. 24 indexed citations
2.
Kawano, Yawara, et al.. (2021). A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells. Biochemical and Biophysical Research Communications. 587. 153–159. 18 indexed citations
3.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2018). Bufalin induces DNA damage response under hypoxic condition in myeloma cells. Oncology Letters. 15(5). 6443–6449. 7 indexed citations
4.
Hata, Hiroyuki, Mitsuharu Ueda, Nao Nishimura, et al.. (2017). Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin. Blood. 130. 5331–5331. 1 indexed citations
5.
Chikamatsu, Kinuyo, Akio Aono, Hiroyuki Hata, et al.. (2017). Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria. Diagnostic Microbiology and Infectious Disease. 90(1). 35–39. 3 indexed citations
6.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2017). Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition. Blood. 130. 5395–5395. 1 indexed citations
7.
Fujiwara, Shiho, Hirotomo Nakata, Koichi Ohshima, et al.. (2016). Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. International Journal of Hematology. 103(6). 718–723. 38 indexed citations
8.
Wada, Naoko, Yawara Kawano, Shiho Fujiwara, et al.. (2014). Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. International Journal of Oncology. 46(3). 963–972. 61 indexed citations
9.
Takamatsu, Yasushi, Kazutaka Sunami, Tsuyoshi Muta, et al.. (2013). Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study. International Journal of Hematology. 98(2). 179–185. 8 indexed citations
10.
Hata, Hiroyuki. (2013). [JSH guideline for multiple myeloma].. PubMed. 54(10). 1850–5. 1 indexed citations
11.
Hata, Hiroyuki. (2011). [Development of novel agents for multiple myeloma; now and the future].. 52(8). 603–608. 1 indexed citations
12.
Tatetsu, Hiro, Shikiko Ueno, Hiroyuki Hata, et al.. (2007). Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth. Cancer Research. 67(11). 5328–5336. 41 indexed citations
13.
Ohkusu, Kiyofumi, Hiroyuki Hata, Mohammad Monir Shah, et al.. (2007). Mycobacterium species identification – A new approach via dnaJ gene sequencing. Systematic and Applied Microbiology. 30(6). 453–462. 24 indexed citations
14.
Nakamura, Miki, Tomomi Gotoh, Yutaka Okuno, et al.. (2006). Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & lymphoma. 47(3). 531–539. 55 indexed citations
15.
Yamaguchi, Motoko, Masahiko Oguchi, Kensei Tobinai, et al.. (2005). Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.. Blood. 106(11). 2685–2685. 7 indexed citations
16.
Hata, Hiroyuki. (2005). Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1α) in human multiple myeloma. Leukemia & lymphoma. 46(7). 967–972. 17 indexed citations
17.
Matsuzaki, Hiromitsu, Hiroyuki Hata, Minoru Yoshida, et al.. (1998). Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure. American Journal of Hematology. 57(1). 77–81. 8 indexed citations
18.
Kagimoto, Tadashi, Hiroyuki Hata, Michihiro Hidaka, et al.. (1997). Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia. Journal of Laboratory and Clinical Medicine. 129(2). 217–223. 7 indexed citations
19.
Matsuzaki, Hiromitsu, Hiroyuki Hata, Norio Asou, et al.. (1992). Human T‐Cell Leukemia Virus‐1‐positive Cell Line Established from a Patient with Small Cell Lung Cancer. Japanese Journal of Cancer Research. 83(5). 450–457. 3 indexed citations
20.
Hata, Hiroyuki, Hiromitsu Matsuzaki, Kenji Tanaka, et al.. (1988). Ectopic production of salivary-type amylase by a lga-λ-type multiple myeloma. Cancer. 62(8). 1511–1515. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Gallardo Breakdown of academic impact, for papers by Benigno C. Valdez Breakdown of academic impact, for papers by Lotte K. Vogel Breakdown of academic impact, for papers by Junji Nishida Breakdown of academic impact, for papers by Clarissa Uhlar Breakdown of academic impact, for papers by J A Kant Breakdown of academic impact, for papers by Nadine Weich Breakdown of academic impact, for papers by Susan B. Dillon Breakdown of academic impact, for papers by N. N. Teng Breakdown of academic impact, for papers by Junichiro Fujimoto
Rankless by CCL
2026